In early cancer research, M Vitale et al found that mutations in HLA‐class I antigens and TAP2 may indicate evasion of host immune pressure, and the accumulation of defects in antigen processing and presentation may in turn lead to reduced recognition by CD8+ T cells.56 The gene discussed is TAP2; the disease is cancer.